GRSF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.37779812401118E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.18850000002868E-06 |
Normal-vs-Stage2 |
1.171610E-04 |
Normal-vs-Stage3 |
5.62883073484954E-14 |
Normal-vs-Stage4 |
3.70010000416698E-09 |
Stage1-vs-Stage2 |
3.333200E-01 |
Stage1-vs-Stage3 |
1.52236999999555E-05 |
Stage1-vs-Stage4 |
2.662300E-03 |
Stage2-vs-Stage3 |
6.390000E-02 |
Stage2-vs-Stage4 |
2.171400E-01 |
Stage3-vs-Stage4 |
5.912600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.74520406406964E-11 |
Normal-vs-AfricanAmerican |
3.72260000000013E-05 |
Normal-vs-Asian |
9.538500E-02 |
Caucasian-vs-AfricanAmerican |
4.200800E-01 |
Caucasian-vs-Asian |
4.713400E-01 |
AfricanAmerican-vs-Asian |
6.724000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.27646806855364E-12 |
Normal-vs-Female |
5.35379999999641E-07 |
Male-vs-Female |
1.229540E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.21059999999862E-05 |
Normal-vs-Age(41-60Yrs) |
6.18309999866895E-08 |
Normal-vs-Age(61-80Yrs) |
4.25000035164658E-11 |
Normal-vs-Age(81-100Yrs) |
3.98249999977729E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.538000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.417200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.886400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.413700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.880500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.412600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.068000E-01 |
Normal-vs-Grade 2 |
1.38390000015143E-07 |
Normal-vs-Grade 3 |
3.12480041841923E-11 |
Normal-vs-Grade 4 |
4.29889457365107E-12 |
Grade 1-vs-Grade 2 |
2.258600E-01 |
Grade 1-vs-Grade 3 |
5.905900E-02 |
Grade 1-vs-Grade 4 |
3.859400E-03 |
Grade 2-vs-Grade 3 |
2.409600E-02 |
Grade 2-vs-Grade 4 |
4.951300E-04 |
Grade 3-vs-Grade 4 |
9.495800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.06849999959024E-07 |
Normal-vs-ccB subtype |
4.36439999695892E-08 |
ccA subtype-vs-ccB subtype |
4.932400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.93739996162878E-09 |
Normal-vs-N1 |
1.421250E-03 |
N0-vs-N1 |
7.723400E-01 |
|
|